Syncona FY20: Martin Murphy discusses FY20 results

Published

11.06.20

Share this page

Related Insights and articles

24.09.21

Alex Hamilton on manufacturing in cell and gene therapy and the role of development partnerships

Life Science industry
Syncona

08.08.23

Modality precision is the new precision in medicine

World class leadership
Syncona

11.06.20

Syncona FY20: Martin Murphy discusses the outlook for Syncona

Syncona

Sign-up for company news alerts

Get the latest RNS, company news, share price information and results from Syncona

RNS alerts
Company alerts

Syncona Investment Management Limited
2nd Floor
8 Bloomsbury Street
London
WC1B 3SR

contact@synconaltd.com

About us
Our people
Portfolio
Sustainability
News and insights
Investors
Contact

Accessibility
Privacy & cookies
Employee privacy notice
Third party privacy notice
Regulatory publications
Modern slavery statement

Syncona Limited is registered in Guernsey no. 55514, registered office Frances House, PO Box 273, Sir William Place, St. Peter Port, Guernsey, GY1 3RD.
Syncona Investment Management Limited is registered in England no. 10497864, 8 Bloomsbury Street, London WC1B 3SR and is authorised and regulated by the FCA. Syncona Limited is managed by Syncona Investment Management Limited.

threethirty.studio

About us
Our people
Portfolio
Sustainability
News and insights
Investors
Contact

GBX 128.40

Change: +1.40 (+1.10%)

Search